开云app官网登录入口网页版-官方正版

#血透#

22篇内容 | 1518人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1466444, encodeId=b9a71466444e1, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=JACC：口服抗凝药不会降低血透房颤患者的栓塞风险, objectType=article, longId=187596, objectId=380b18e596bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=380b18e596bf, replyNumber=0, likeNumber=76, createdTime=2020-02-08, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=380b18e596bf, moduleTitle=JACC：口服抗凝药不会降低血透房颤患者的栓塞风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=380b18e596bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466443, encodeId=142d1466443b4, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=血透临床技师的春天在哪里, objectType=article, longId=177212, objectId=89f21e7212fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f21e7212fc, replyNumber=0, likeNumber=63, createdTime=2019-08-09, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f21e7212fc, moduleTitle=血透临床技师的春天在哪里, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=89f21e7212fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466442, encodeId=2172146644200, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=“炸响惊雷”独立血透中心或遭遇大调整, objectType=article, longId=176727, objectId=50fe1e67277f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50fe1e67277f, replyNumber=0, likeNumber=0, createdTime=2019-08-04, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50fe1e67277f, moduleTitle=“炸响惊雷”独立血透中心或遭遇大调整, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=50fe1e67277f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466441, encodeId=a972146644151, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=69名血透患者院内感染的启示, objectType=article, longId=168036, objectId=29d0168036d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29d0168036d3, replyNumber=0, likeNumber=85, createdTime=2019-06-12, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29d0168036d3, moduleTitle=69名血透患者院内感染的启示, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=29d0168036d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466440, encodeId=3de6146644057, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=江苏东台69人感染丙肝背后：“不规范”的血透室, objectType=article, longId=167467, objectId=733416e467c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=733416e467c6, replyNumber=0, likeNumber=80, createdTime=2019-06-03, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=733416e467c6, moduleTitle=江苏东台69人感染丙肝背后：“不规范”的血透室, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=733416e467c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466439, encodeId=99351466439ec, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=血透中血管通路并发症，中心静脉导管的使用及并发症, objectType=article, longId=163602, objectId=34d4163602f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34d4163602f1, replyNumber=0, likeNumber=76, createdTime=2019-04-05, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34d4163602f1, moduleTitle=血透中血管通路并发症，中心静脉导管的使用及并发症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=34d4163602f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466438, encodeId=8bcb1466438c7, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK, objectType=article, longId=150658, objectId=e80a15065895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e80a15065895, replyNumber=0, likeNumber=58, createdTime=2018-10-11, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e80a15065895, moduleTitle=Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e80a15065895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466437, encodeId=0b7d146643e02, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=维持性血透患者10大常规检查，你都知道吗？, objectType=article, longId=145831, objectId=db7a14583104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db7a14583104, replyNumber=0, likeNumber=64, createdTime=2018-08-05, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db7a14583104, moduleTitle=维持性血透患者10大常规检查，你都知道吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=db7a14583104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466436, encodeId=87f814664368d, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=一年新增150余家血透中心看专家解读中国血透产业政策, objectType=article, longId=141500, objectId=f9ec141500f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ec141500f1, replyNumber=0, likeNumber=66, createdTime=2018-06-25, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ec141500f1, moduleTitle=一年新增150余家血透中心看专家解读中国血透产业政策, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f9ec141500f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466435, encodeId=4969146643555, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=Clin J Am Soc Nephrol：阿片类镇痛药影响血透患者不良结局？, objectType=article, longId=141356, objectId=1632141356a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1632141356a5, replyNumber=0, likeNumber=0, createdTime=2018-06-24, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1632141356a5, moduleTitle=Clin J Am Soc Nephrol：阿片类镇痛药影响血透患者不良结局？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1632141356a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466434, encodeId=8e8614664346f, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=JAHA：二甲双胍可增加血透糖尿病患者的卒中发生风险, objectType=article, longId=120526, objectId=21061205262b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21061205262b, replyNumber=0, likeNumber=79, createdTime=2017-11-19, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21061205262b, moduleTitle=JAHA：二甲双胍可增加血透糖尿病患者的卒中发生风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=21061205262b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466433, encodeId=6709146643366, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=3家血透产品企业被要求限期整改, objectType=article, longId=119691, objectId=63501196916f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63501196916f, replyNumber=0, likeNumber=0, createdTime=2017-11-13, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63501196916f, moduleTitle=3家血透产品企业被要求限期整改, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=63501196916f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466432, encodeId=ab5c14664325f, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=Ann Pharmacother：终末期肾病血透患者应如何给予左乙拉西坦？, objectType=article, longId=117735, objectId=8ad411e735fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad411e735fc, replyNumber=0, likeNumber=64, createdTime=2017-10-28, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad411e735fc, moduleTitle=Ann Pharmacother：终末期肾病血透患者应如何给予左乙拉西坦？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8ad411e735fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466431, encodeId=03331466431a6, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=重复 J Am Heart Assoc：血透糖尿病患者心血管风险知多少, objectType=article, longId=107974, objectId=22ac10e97495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22ac10e97495, replyNumber=0, likeNumber=71, createdTime=2017-08-09, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22ac10e97495, moduleTitle=重复 J Am Heart Assoc：血透糖尿病患者心血管风险知多少, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=22ac10e97495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466430, encodeId=251d1466430a3, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=J Am Soc Nephrol：HDL胆固醇的流出能力不能预测血透患者心血管发生的风险, objectType=article, longId=79683, objectId=92d1e968316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92d1e968316, replyNumber=0, likeNumber=53, createdTime=2016-10-11, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92d1e968316, moduleTitle=J Am Soc Nephrol：HDL胆固醇的流出能力不能预测血透患者心血管发生的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=92d1e968316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466429, encodeId=2a911466429b5, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=PLoS One：血肌酐可预测血透患者死亡风险, objectType=article, longId=69597, objectId=e00e6959e7f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e00e6959e7f, replyNumber=0, likeNumber=60, createdTime=2016-06-02, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e00e6959e7f, moduleTitle=PLoS One：血肌酐可预测血透患者死亡风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e00e6959e7f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466428, encodeId=69b4146642836, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=JACC：血透患者肠道胆固醇吸收水平或影响阿托伐他汀治疗效果, objectType=article, longId=52222, objectId=d2155222281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2155222281, replyNumber=0, likeNumber=70, createdTime=2015-06-19, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2155222281, moduleTitle=JACC：血透患者肠道胆固醇吸收水平或影响阿托伐他汀治疗效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d2155222281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466427, encodeId=db9e146642eef, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=JACC：肠道胆固醇吸收率低的血透患者更能获益于阿托伐他汀治疗, objectType=article, longId=51620, objectId=c4eb516208a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4eb516208a, replyNumber=0, likeNumber=64, createdTime=2015-06-05, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4eb516208a, moduleTitle=JACC：肠道胆固醇吸收率低的血透患者更能获益于阿托伐他汀治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c4eb516208a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466426, encodeId=31701466426c7, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=IJNS：遵循护士的指导训练可明显提高血透患者的身体素质, objectType=article, longId=51234, objectId=098851234c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098851234c9, replyNumber=0, likeNumber=73, createdTime=2015-05-28, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098851234c9, moduleTitle=IJNS：遵循护士的指导训练可明显提高血透患者的身体素质, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=098851234c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466425, encodeId=c8a5146642552, content=<a href='/topic/show?id=1a808996802' target=_blank style='color:#2F92EE;'>#血透#</a>, objectTitle=华法林治疗和低血浆白蛋白水平是血透患者发生钙化防御的重要危险因素, objectType=article, longId=6388, objectId=9313638891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9313638891, replyNumber=0, likeNumber=60, createdTime=2012-05-21, rootId=0, userName=luwei02, userId=950a6811421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9313638891, moduleTitle=华法林治疗和低血浆白蛋白水平是血透患者发生钙化防御的重要危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9313638891)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

血透

2020-05-29

luwei02 (审核中...)

前往app查看评论内容

#血透#

JACC：口服抗凝药不会降低血透房颤患者的栓塞风险

2020-02-08

luwei02 (审核中...)

前往app查看评论内容

#血透#

血透临床技师的春天在哪里

2019-08-09

luwei02 (审核中...)

前往app查看评论内容

#血透#

“炸响惊雷”独立血透中心或遭遇大调整

2019-08-04

luwei02 (审核中...)

前往app查看评论内容

#血透#

69名血透患者院内感染的启示

2019-06-12

luwei02 (审核中...)

前往app查看评论内容

#血透#

江苏东台69人感染丙肝背后：“不规范”的血透室

2019-06-03

luwei02 (审核中...)

前往app查看评论内容

#血透#

血透中血管通路并发症，中心静脉导管的使用及并发症

2019-04-05

luwei02 (审核中...)

前往app查看评论内容

#血透#

Am J Kidney Dis：持续血透患者：两大常用β-阻断剂大PK

2018-10-11

luwei02 (审核中...)

前往app查看评论内容

#血透#

维持性血透患者10大常规检查，你都知道吗？

2018-08-05

luwei02 (审核中...)

前往app查看评论内容

#血透#

一年新增150余家血透中心看专家解读中国血透产业政策

2018-06-25

luwei02 (审核中...)

前往app查看评论内容

#血透#

Clin J Am Soc Nephrol：阿片类镇痛药影响血透患者不良结局？

2018-06-24

luwei02 (审核中...)

前往app查看评论内容

#血透#

JAHA：二甲双胍可增加血透糖尿病患者的卒中发生风险

2017-11-19

luwei02 (审核中...)

前往app查看评论内容

#血透#

3家血透产品企业被要求限期整改

2017-11-13

luwei02 (审核中...)

前往app查看评论内容

#血透#

Ann Pharmacother：终末期肾病血透患者应如何给予左乙拉西坦？

2017-10-28

luwei02 (审核中...)

前往app查看评论内容

#血透#

重复 J Am Heart Assoc：血透糖尿病患者心血管风险知多少

2017-08-09

luwei02 (审核中...)

前往app查看评论内容

#血透#

J Am Soc Nephrol：HDL胆固醇的流出能力不能预测血透患者心血管发生的风险

2016-10-11

luwei02 (审核中...)

前往app查看评论内容

#血透#

PLoS One：血肌酐可预测血透患者死亡风险

2016-06-02

luwei02 (审核中...)

前往app查看评论内容

#血透#

JACC：血透患者肠道胆固醇吸收水平或影响阿托伐他汀治疗效果

2015-06-19

luwei02 (审核中...)

前往app查看评论内容

#血透#

JACC：肠道胆固醇吸收率低的血透患者更能获益于阿托伐他汀治疗

2015-06-05

luwei02 (审核中...)

前往app查看评论内容

#血透#

IJNS：遵循护士的指导训练可明显提高血透患者的身体素质

2015-05-28

luwei02 (审核中...)

前往app查看评论内容

#血透#

华法林治疗和低血浆白蛋白水平是血透患者发生钙化防御的重要危险因素

2012-05-21

科室
- - 订阅+
  - 更多科室
工具
服务